BioAtla, Inc. (BCAB)
1.26
-0.06
(-4.55%)
USD |
OTCM |
Sep 08, 16:00
BioAtla 1 Year Total Returns (Daily) : -95.88% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | -95.88% |
| September 04, 2026 | -94.71% |
| September 03, 2026 | -94.68% |
| September 02, 2026 | -94.62% |
| September 01, 2026 | -95.26% |
| August 31, 2026 | -92.58% |
| August 28, 2026 | -91.74% |
| August 27, 2026 | -85.94% |
| August 26, 2026 | -84.65% |
| August 25, 2026 | -81.69% |
| August 24, 2026 | -81.58% |
| August 21, 2026 | -82.21% |
| August 20, 2026 | -83.05% |
| August 19, 2026 | -82.33% |
| August 18, 2026 | -83.63% |
| August 17, 2026 | -83.36% |
| August 14, 2026 | -83.03% |
| August 13, 2026 | -82.42% |
| August 12, 2026 | -81.73% |
| August 11, 2026 | -80.69% |
| August 10, 2026 | -80.32% |
| August 07, 2026 | -81.78% |
| August 06, 2026 | -82.22% |
| August 05, 2026 | -81.00% |
| August 04, 2026 | -79.79% |
| Date | Value |
|---|---|
| August 03, 2026 | -80.24% |
| July 31, 2026 | -81.68% |
| July 30, 2026 | -81.37% |
| July 29, 2026 | -81.47% |
| July 28, 2026 | -80.06% |
| July 27, 2026 | -80.83% |
| July 24, 2026 | -82.12% |
| July 23, 2026 | -82.69% |
| July 22, 2026 | -80.13% |
| July 21, 2026 | -78.04% |
| July 20, 2026 | -78.98% |
| July 17, 2026 | -78.68% |
| July 16, 2026 | -79.27% |
| July 15, 2026 | -78.37% |
| July 14, 2026 | -79.65% |
| July 13, 2026 | -79.61% |
| July 10, 2026 | -80.24% |
| July 09, 2026 | -80.81% |
| July 08, 2026 | -81.50% |
| July 07, 2026 | -78.86% |
| July 06, 2026 | -75.64% |
| July 02, 2026 | -78.93% |
| July 01, 2026 | -79.08% |
| June 30, 2026 | -79.09% |
| June 29, 2026 | -80.05% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 213.2% |
| Oncolytics Biotech, Inc. | -37.11% |
| Sangamo Therapeutics, Inc. | -69.35% |
| Sarepta Therapeutics, Inc. | 18.98% |
| Anixa Biosciences, Inc. | -2.68% |